COMMUNIQUÉS West-GlobeNewswire

Wegovy Pill vs Wegovy Shot: Oral vs Injectable Semaglutide Differences — 2026 FDA Launch Analysis via Ro.co
13/01/2026
Comprehensive comparison of daily oral vs weekly injectable Wegovy following Novo Nordisk's January 2026 FDA approval of the first oral GLP-1 for chronic weight management — Ro.co telehealth access pathway examination [...]
Metabo Drops 2026: Is It Legit? Ingredients, Safety Facts, and Consumer Analysis
13/01/2026
Consumer searches for supplement legitimacy increased 26% year-over-year as transparency becomes central purchasing criterion — industry analysis examines what drives "Is It Legit?" search behavior and how liquid [...]
Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia
12/01/2026
- SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations - - Dosing of the first participant in the Phase 1b FALCON trial has been completed, with initial data expected in H2 2026, [...]
IBA SA – NOTIFICATION TRANSPARENCE
12/01/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 12 janvier 2026, 22:30 Résumé de la notification IBA (Ion Beam Applications SA), le [...]
IBA – TRANSPARENCY NOTIFICATION
12/01/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 12, 2026 10:30 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
CareMed Has Been Selected as a National Specialty Pharmacy Provider for MYQORZO™ (aficamten)
12/01/2026
NEW HYDE PARK, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- CareMed ® , an independent specialty pharmacy, has been selected as a pharmacy partner by Cytokinetics for MYQORZO™ ( aficamten ), indicated for the treatment of [...]
Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer
12/01/2026
WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026
12/01/2026
BANNOCKBURN, Ill., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion [...]
Best Electrolyte Supplement Analysis 2026: Seaonic Challenges Top Hydration Packets With Ocean-Sourced Minerals
13/01/2026
A deep-dive into what's driving the shift toward seawater-derived electrolytes—and how Seaonic's published disclosures compare with common verification criteria DENVER, CO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disclaimer: [...]
Wegovy Pill Legitimacy Examined: 2026 Consumer Analysis Investigates Ro's Oral GLP-1 Access Pathway and No-Insurance Cash-Pay Options
13/01/2026
As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's direct-to-patient distribution model, pricing transparency, and telehealth access structure for patients [...]
Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options
13/01/2026
Consumer Report Details Low Testosterone Treatment Costs, LabCorp and Quest Lab Testing, Licensed Provider Access, and What Men Need to Know Before Starting Online TRT WILMINGTON, DE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Best Hair Regrowth Formula 2026 (BioGrow RX): Consumer Report Compares Biotin Supplements to Topical Treatments
13/01/2026
2026 Hair Wellness Report: Biotin Complex vs Topical Serums – Format Selection, Label Transparency, and Daily Routine Fit NORTH LARGO, FL, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational [...]
Glo & Spa-rkle Aesthetics and Medical Spa Announces Relocation to a State-of-the-Art Facility in Lubbock, Texas
12/01/2026
Expanded Services and Enhanced Client Experience Await at New Location Lubbock, TX, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Glo & Spa-rkle Aesthetics and Medical Spa , a leading name in aesthetic and wellness services, is [...]
Precision Neuroscience™ and Medtronic Partner to Integrate Layer 7 Brain–Computer Interface with Medtronic Neurosurgical Platform
12/01/2026
NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced a strategic partnership with Medtronic to advance neurosurgery, leveraging Precision’s brain – computer [...]
IBA SA – NOTIFICATION TRANSPARENCE
12/01/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 12 janvier 2026, 22:00 Résumé de la notification IBA (Ion Beam Applications SA), le [...]
IBA – TRANSPARENCY NOTIFICATION
12/01/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 12, 2026 10:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025
12/01/2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Avertissement : Le présent [...]
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
12/01/2026
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Notice: This [...]
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
12/01/2026
WESTLAKE VILLAGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation ( NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the [...]

Pages